Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lac302
    Member
    • Dec 2012
    • 64

    #1

    Nextera XT low complexity pooling, V3 reagent kit

    A couple questions about the Nextera XT kit. The protocol is written as if you are using amplicons.

    1. What is the size distribution of fragments post tagmentation assuming loading 1ng of gDNA (metagenome)?

    2. What is the binding capacity of the normalization beads?

    3. If pooling 1-3 libraries how much of each should be added the HT1 buffer. I was told by tech support to load only 5ul of ea library, bring up the volume of HT1 to 600ul. This doesn't seem right to me. Protocol states 5ul of ea library pooled, 24ul of this into 576 HT1 to maintain 1:25 dilution.
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    1- Tagmented fragments size using XT kit for good quality high molecular weight DNA is 100-2000 bp. Completed libraries sizes varies from 300 bp above depending on ratio of beads used for clean-up.
    2- Illumina does not reveal that.
    3- We stop after cleaning PCR and follow standard protocols for sequencing which is QPCR quantification, pooling and sequencing. Using normaliser beads gives unreliable results.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      Yesterday, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 02:55 AM
    0 responses
    10 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    12 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Working...